1, 2, 3-TRIAZOLE DERIVATIVES FOR USE AS STEAROYL-COA DESATURASE INHIBITORS

(19)

(11)

EP 2 368 887 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	16.04.2014 Bulletin 2014/16

(45)	Mention of the grant of the patent:
	26.02.2014 Bulletin 2014/09

(21)	Application number: 11168642.4

(22)	Date of filing: 07.11.2008

(27)	Previously filed application: 07.11.2008 EP 08846247

(51)

International Patent Classification (IPC):

C07D 249/04^(2006.01)
A61K 31/4192^(2006.01)

C07D 413/12^(2006.01)
A61P 3/06^(2006.01)

(54)	1, 2, 3-TRIAZOLE DERIVATIVES FOR USE AS STEAROYL-COA DESATURASE INHIBITORS 1,2,3-TRIAZOLDERIVATE ZUR VERWENDUNG ALS INHIBITOREN VON STEAROYL-COA-DESATURASE DÉRIVÉS DE 1,2,3-TRIAZOLE DESTINÉS À ÊTRE UTILISÉS COMME INHIBITEURS DE LA STÉAROYL-COA DÉSATURASE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
	Designated Extension States:
	AL BA MK RS

(30)

Priority:

09.11.2007 GB 0722077

(43)	Date of publication of application:
	28.09.2011 Bulletin 2011/39

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	08846247.8 / 2207770

(73)	Proprietor: GlaxoSmithKline LLC
	Wilmington, Delaware 19808 (US)

(72)	Inventors:
	Bouillot, Anne, Marie, Jeanne 91951 Les Ulis (FR) Laroze, Alain 91951 Les Ulis (FR) Trottet, Lionel 91951 Les Ulis (FR)

(74)	Representative: Hillier, Mark
	GlaxoSmithKline Global Patents (CN9-25.1) 980 Great West Road GB-Brentford, Middlesex TW8 9GS GB-Brentford, Middlesex TW8 9GS (GB)

(56)

References cited: :

WO-A-2005/011657
WO-A1-2005/000821

WO-A-2008/138917

CALDERONE, V. ET AL.: "1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, no. 11, 7 March 2008 (2008-03-07) , pages 2618-2626, XP002513784,

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).